文献速递妇科

局部晚期宫颈癌腹主动脉旁淋巴结转移预测模型

Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
PubMed 文献 · Gynecol Oncol · 2016-11-14

本研究回顾性分析2009至2016年两家三级中心245例接受腹主动脉旁淋巴结清扫的局部晚期宫颈癌患者,构建并内部验证腹主动脉旁淋巴结转移预测模型。模型纳入MRI肿瘤大小和PET/CT腹主动脉旁淋巴结状态两个独立预测因子,区分度与校准良好(Bootstrap校正一致性指数=0.886;95%CI=0.825-0.947),将患者分为低、中、高危三组,预测转移概率分别为2.9%、20.8%和76.2%。

要点

  • 34例(13.9%)经病理证实腹主动脉旁淋巴结转移。
  • PET/CT阴性者中16/222(7.2%)有腹主动脉旁淋巴结转移。
  • 模型预测低、中、高危组转移概率分别为2.9%、20.8%、76.2%。

核心结论

  • 构建了预测局部晚期宫颈癌腹主动脉旁淋巴结转移的稳健模型,可能改进临床试验设计并帮助临床医生决定是否行淋巴结分期手术。

研究设计与样本

  • 回顾性分析2009至2016年两家三级中心连续接受腹主动脉旁淋巴结清扫的局部晚期宫颈癌患者245例。
  • 构建多变量逻辑回归模型并内部验证,分析前基于似然比预设风险分组。

主要发现

  • 34例(13.9%)经病理证实腹主动脉旁淋巴结转移。
  • PET/CT显示腹主动脉旁淋巴结阴性的患者中16/222(7.2%)有腹主动脉旁淋巴结转移。
  • PET/CT显示腹主动脉旁淋巴结和盆腔淋巴结均阴性的患者中11/105(10.5%)有腹主动脉旁淋巴结转移。
  • MRI肿瘤大小和PET/CT腹主动脉旁淋巴结状态是腹主动脉旁淋巴结转移的独立预测因子。
  • 模型区分度和校准良好(Bootstrap校正一致性指数=0.886;95%CI=0.825-0.947)。

关键数值与推荐

  • 模型将169例(69%)、52例(22%)、23例(9%)分别归入低、中、高危组。
  • 低、中、高危组预测腹主动脉旁淋巴结转移概率分别为2.9%、20.8%、76.2%。

临床怎么用

  • 作者认为该模型可能改进临床试验设计并帮助临床医生决定是否行淋巴结分期手术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Concurrent chemoradiotherapy is usually administered to patients with locally advanced cervical cancer (LACC). Extended-field chemoradiotherapy is required if para-aortic lymph node (PALN) metastasis is detected. This study aimed to construct a prediction model for PALN metastasis in patients with LACC before definitive treatment. METHODS: Between 2009 and 2016, all consecutive patients with LACC who underwent para-aortic lymphadenectomy at two tertiary centers were retrospectively analyzed. A multivariate logistic model was constructed, from which a prediction model for PALN metastasis was developed and internally validated. Before analysis, risk grouping was predefined based on the likelihood ratio. RESULTS: In total, 245 patients satisfied the eligibility criteria. Thirty-four patients (13.9%) had pathologically proven PALN metastases. Additionally, 16/222 (7.2%) patients with negative PALNs on positron emission tomography/computed tomography (PET/CT) had PALN metastasis. Moreover, 11/105 (10.5%) patients with both negative PALNs and positive pelvic lymph nodes on PET/CT had PALN metastasis. Tumor size on magnetic resonance imaging and PALN status on PET/CT were independent predictors of PALN metastasis. The model incorporating these two predictors displayed good discrimination and calibration (bootstrap-corrected concordance index=0.886; 95% confidence interval=0.825-0.947). The model categorized 169 (69%), 52 (22%), and 23 (9%) patients into low-, intermediate-, and high-risk groups, respectively. The predicted probabilities of PALN metastasis for these groups were 2.9, 20.8, and 76.2%, respectively. CONCLUSION: We constructed a robust model predicting PALN metastasis in patients with LACC that may improve clinical trial design and help clinicians determine whether nodal-staging surgery should be performed.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Shim SH, Kim DY, Lee SJ, et al. Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer. Gynecol Oncol. 2016. PMID: 27855989. doi:10.1016/j.ygyno.2016.11.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。